Because of these signaling complexities and an increasing trend of drug-resistance, a molecular target that plays a central role in diverse oncogenic signaling pathways have long been sought.
← all excerpts
Anti-tumor activity of WK88-1, a novel geldanamycin derivative, in gefitinib-resistant non-small cell lung cancers with Met amplification.
1
—
—